SIMBRINZA is a prescription ophthalmic suspension used to help lower elevated intraocular pressure (pressure inside the eye). Increased intraocular pressure is commonly associated with open-angle glaucoma or ocular hypertension. SIMBRINZA combines two active ingredients that work together to reduce fluid production within the eye, thereby helping to control eye pressure. It is typically prescribed when a single medication does not provide sufficient pressure reduction. This medicine is for use in the eyes only and should be used exactly as directed by a healthcare professional.

Active Ingredient(s) / Generic Name

• Brinzolamide 1% w/v

• Brimonidine tartrate 0.2% w/v

Generic Names: Brinzolamide and Brimonidine Tartrate

Brand Name / Manufacturer / Marketer

• Brand Name: SIMBRINZA

• Manufacturer/Marketer: Novartis Pharmaceuticals (Alcon/Novartis division, depending on region)

Indications / Uses

• Reduction of elevated intraocular pressure in adults

• Management of open-angle glaucoma

• Treatment of ocular hypertension when combination therapy is appropriate

SIMBRINZA is usually prescribed when treatment with a single pressure-lowering eye drop is not adequate.

Storage Instructions

• Store below 30°C

• Do not freeze

• Keep the bottle tightly closed when not in use

• Protect from light

• Keep out of reach of children

• Follow any additional storage instructions provided on the product label

Disclaimer
This product description is provided for informational purposes only. SIMBRINZA is a prescription medicine and should be used only under the supervision of a qualified healthcare professional. Consult your doctor or pharmacist for proper usage, dosing instructions, and possible side effects. Do not use this medication without a valid prescription.